You are at:Home»Popular Topics»Cancer Drug News»Protected: Novel triplet therapy for newly diagnosed multiple myeloma patients now PBS listed

Cancer Drug News

Protected: Novel triplet therapy for newly diagnosed multiple myeloma patients now PBS listed

By ONA Editor June 1, 2020 No Comments

About Author

ONA Editor

The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.

This post is password protected. Enter the password to view comments.

ENA 20: Vaccine designed to treat and prevent lung, bowel and pancreatic cancer shows promise in the lab

Radiotherapy tattoos can be a painful reminder of cancer – but 3D imaging could be the solution

ENA 20: Vaccine designed to treat and prevent lung, bowel and pancreatic cancer shows promise in the lab

Radiotherapy tattoos can be a painful reminder of cancer – but 3D imaging could be the solution

Protected: Novel triplet therapy for newly diagnosed multiple myeloma patients now PBS listed

About Author

ENA 20: Vaccine designed to treat and prevent lung, bowel and pancreatic cancer shows promise in the lab

Radiotherapy tattoos can be a painful reminder of cancer – but 3D imaging could be the solution

ENA 20: Vaccine designed to treat and prevent lung, bowel and pancreatic cancer shows promise in the lab

Radiotherapy tattoos can be a painful reminder of cancer – but 3D imaging could be the solution

About Author

Related Posts

FDA approves carfilzomib and daratumumab with dexamethasone for multiple myeloma

Protected: Neoadjuvant treatment key to unlocking benefits of PBS-listed Kadcyla® (trastuzumab emtansine) in the adjuvant setting

Genetic test could pick out ‘ultra high risk’ bone marrow cancer patients